Search
Wednesday 16 September 2015
  • :
  • :
Latest Update

News Buzz: Rex Energy Corporation (NASDAQ:REXX), Willis Group Holdings PLC (NYSE:WSH), Sarepta Therapeutics Inc (NASDAQ:SRPT), Canadian Solar Inc. (NASDAQ:CSIQ)

On Monday, Shares of Rex Energy Corporation (NASDAQ:REXX), lost -6.40% to $2.34.

Rex Energy Corporation, declared that its bank group has reaffirmed the existing $350 million borrowing base under the company’s senior secured credit facility. Under the terms of the credit agreement, the bank group re-determines the borrowing base semi-annually utilizing the bank’s estimates of reserves and future oil and gas prices. In addition, the bank group approved an amendment to the credit agreement which, among other things, allows the company to repurchase up to $25 million of Rex Energy common stock or senior unsecured notes, subject to certain terms and conditions.

“We appreciate the support of our bank group as we continue to navigate through the challenging price environment,” said Tom Stabley, Rex Energy’s President and Chief Executive Officer. “Preserving our liquidity and flexibility is a key component of our strategy. We continue to pursue planned transactions to further reduce our capital expenditure budget, improvement overall liquidity, and hold by production the company’s core position in the Appalachian Basin.”

Rex Energy Corporation operates as an independent oil, natural gas liquid, and natural gas company in the Appalachian and Illinois basins in the United States. The company focuses on the Marcellus Shale, Utica Shale, and Burkett Shale drilling and exploration activities in the Appalachian Basin, in addition to on developmental oil drilling and the implementation of improved oil recovery on its properties in the Illinois Basins.

Shares of Willis Group Holdings PLC (NYSE:WSH), declined -0.71% to $42.25, during its last trading session.

Willis Group Holdings, declared the appointment of Toby Wemyss as Global Head of Placement. He takes up this new role with immediate effect and succeeds David Martin, who will be leaving the company.

In this role, Wemyss will drive the ongoing development of Willis’s global placement strategy, leading the firm’s worldwide network of placement leaders.

Commenting on the appointment, Dominic Casserley, CEO of Willis Group, said: “Willis’s global placement capabilities and services are central to the firm’s client value proposition. Toby’s wide-ranging experience, and in particular his hands-on knowledge of the wholesale and retail broking markets worldwide, make him ideally placed to lead our ongoing efforts to bring the best of our global talent, expertise and capabilities to our clients. Toby will lead a team with a true focus on working closely with carriers to provide better products and solutions to meet our clients’ unique needs.”

Willis Group Holdings Public Limited Company provides insurance brokerage, reinsurance, and risk administration consulting services worldwide. It provides services to aerospace clients, counting aircraft manufacturers, air cargo handlers and shippers, airport managers, and other general aviation companies; and advisory services, such as claims recovery, contract and leasing risk administration, safety services, and market information.

At the end of Monday’s trade, Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), gained 2.31% to $36.77.

Sarepta Therapeutics, declared that administration will be presenting a company overview and update at the 2015 Morgan Stanley Global Healthcare Conference in New York, NY. Edward Kaye, Sarepta’s interim chief executive officer and chief medical officer, will represent the company in a fireside chat on Thursday, September 17 at 4:40 PM Eastern Time.

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. Its lead product candidate is Eteplirsen, an antisense phosphorodiamidate morpholino oligomer therapeutic, which is in Phase III clinical development stage for the treatment of individuals with Duchenne muscular dystrophy (DMD), a rare genetic muscle-wasting disease caused by the absence of dystrophin.

Finally, Canadian Solar Inc. (NASDAQ:CSIQ), ended its last trade with -1.27% loss, and closed at $18.72.

Canadian Solar Inc., declared that the company will take part in the 2015 Solar Power International (SPI) exhibition to be held September 14-17, 2015 at the Anaheim Convention Center in Anaheim, California.

During this annual exhibition, Canadian Solar will introduce several new products, counting-

  • The Canadian Solar Smart DC module (CS6P-260|265P-SD): An integrated Canadian Solar PV module featuring the SolarEdge OPJ-300-LV DC power optimizer
  • The Canadian Solar 36 kW string inverter, which is the latest addition to the company’s 1000V UL, three-phase CSI-KTL-CT inverter family
  • The Canadian Solar 72-cell, 1500V Diamond CS6X-P-FG PV module

“Leading the DC optimizer market, SolarEdge believes that by embedding SolarEdge’s power optimizers directly into the modules during the manufacturing process, this will assist accelerate the pace of PV adoption around the world,” stated Lior Handelsman, VP of Marketing and Product Strategy of SolarEdge Technologies. “We are happy that an important player, such as Canadian Solar, has joined us on this mission to provide optimized PV solutions designed to lower the cost of solar energy.”

Canadian Solar Inc., together with its auxiliaries, designs, develops, manufactures, and sells solar wafers, cells, and solar power products worldwide. The company operates in two segments, Module and Energy.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *